Prostatic Adenomectomy and Comorbidities: Frequency and Management at the Urology Department of the Ignace Deen National Hospital in Conakry
- 1 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 2 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 3 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 4 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 5 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 6 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 7 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 8 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 9 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 10 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 11 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
- 12 Maitre-Assistant à la Faculté des Sciences et Techniques de la Santé, Université Gamal Abdel Nasser de Conakry, Conakry, Guinée
Abstract
<b>Goal</b>: To determine the type of comorbidity and highlight the complications of adenomectomy and comorbidities. <b>Material</b><b> </b><b>and</b><b> </b><b>Methods</b>: This is a prospective, descriptive, cross-sectional study lasting six (6) months, from July 1, 2022 to December 31, 2022. Patients with BPH on comorbidity condition taken care of during the study period AND have agreed to participate in the study. <b>Results</b>: During our study, 49 cases of benign prostatic hypertrophy with comorbidities were collected, representing a frequency of 29%. The average age ranges for the patients were 43 - 70 years. The age group most affected was 70 to 79 years old (38.80%). Nocturnal urinary frequency was the main reason for consultation present in all our patients. The most frequent comorbidity was hypertension, <i>i.e.</i> 83.70%. The PSA rate between 4 and 10 was the most represented, <i>i.e.</i> 42.86%. The prostate volume was between 61 and 100 ml in 40.82% of patients. Histology showed that it was a benign adenomatous hypertrophy of the prostate in 85.70% and a prostatic adenomyoma in 14.29%. Trans-bladder adenomectomy alone was the most performed technique, <i>i.e.</i> 49%, followed by trans urethral resection of the prostate, <i>i.e.</i> 38.80%. Retention of urine after removal of the catheter was the most observed complication, <i>i.e.</i> 12.20%. <b>Conclusion</b>: Benign prostatic hypertrophy with comorbidities constitutes a frequent association. Because their presence can affect effectiveness and lead to complications.
- Peyronnet, B., Seisen, T., Phé, V., Misrai, V., de la Taille, A. and Roupret, M. (2016) Symptomes du bas appareil urinaire secondaire a une hyperplasie benigne de la prostate et dysfonction erectile. La Presse Médicale , 46, 145-153. https://doi.org/10.1016/j.lpm.2016.09.002
- Robert, G., De La Taille, A. and Descazeaud, A. (2018) Données épidémiologiques en rapport avec la prise en charge de l’HBP. Progrès en Urologie , 28, 803-812. https://doi.org/10.1016/j.purol.2018.08.005
- Adakal, O., Rouga, M.M., Abdoulaye, M.B., Adamou, H., Maikassoua, M., Mounkeila, I., et al. (2021) Hypertrophie Bénigne de la Prostate au Centre Hospitalier Régional de Maradi: Aspects Cliniques, Thérapeutiques et Pronostiques. Health Sciences and Disease , 22, 93-97.
- Pan, J.G., Jiang, C., Luo, R. and Zhou, X. (2014) Association of Metabolic Syndrome and Benign Prostatic Hyperplasia in Chinese Patients of Different Age Decades. Ur o logia Internationalis , 93, 10-16. https://doi.org/10.1159/000354026
- Parsons, J.K., Sarma, A.V., McVary, K. and Wei, J.T. (2009) Obesity and Benign Prostatic Hyperplasia: Clinical Connections, Emerging Etiological Paradigms and Future Directions. Journal of Urology , 182, S27-S31. http://www.jurology.com/doi/10.1016/j.juro.2009.07.086 https://doi.org/10.1016/j.juro.2009.07.086
- Barry Delongchamps, N., Robert, G., Descazeaud, A., Cornu, J.-N., Azzouzi, A.R., Haillot, O., et al. (2012) Traitement chirurgical de l’hyperplasie bénigne de la prostate par thermothérapie et autres techniques émergentes : Revue de littérature du CTMH de l’AFU. Progrès en Urologie , 22, 87-92. https://doi.org/10.1016/j.purol.2011.08.029
- Hoke, G.P. (2008) Épidémiologie de l’hyperplasie bénigne de la prostate et Comorbidités dans les populations de minorités raciales et ethniques. The American Jou r nal of Medicine , 121, 8. https://doi.org/10.1016/j.amjmed.2008.05.021
- Misraï, V., Barry Delongchamps, N., Lebdai, S., Azzouzi, A.R., Benchikh, A., Cornu, J.N., et al. (2015) Complications graves et inattendues de la chirurgie de l’hyperplasie bénigne de prostate : Résultats de l’enquête du CTMH auprès des urologues de l’AFU. Progrès en Urologie , 25, 583-589. https://doi.org/10.1016/j.purol.2015.06.006
- Botcho, G., Kpatcha, T.M., Tengue, K., Dossouvi, T., Sewa, E.V., Simlawo, K., et al. (2018) Morbidité et mortalité après adénomectomies prostatiques par voie transvésicale au CHU Kara (Togo). African Journal of Urology , 24, 353-358. https://doi.org/10.1016/j.afju.2018.01.008